SPG20 抗体 (N-Term)
Our Local Distributor
北京 101111
Quick Overview for SPG20 抗体 (N-Term) (ABIN954908)
抗原
See all SPG20 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 24-54, N-Term
-
特异性
- This antibody recognizes Spartin / SPG20 at N-term.
-
交叉反应 (详细)
- Species reactivity (tested):Human
-
纯化方法
- Purified through a Protein A column followed by peptide affinity purification
-
免疫原
- Synthetic peptide - KLH conjugated - corresponding to the N-terminal region (between 24-54aa) of human Spartin / SPG20
-
亚型
- Ig Fraction
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.25 mg/mL
-
缓冲液
- PBS with 0.09 % (W/V) Sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freezing and thawing.
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
别名
- Spartin / SPG20
-
背景
- Spartin / SPG20 is a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor.Synonyms: KIAA0610, Spastic paraplegia 20 protein, TAHCCP1, Trans-activated by hepatitis C virus core protein 1
-
基因ID
- 23111
-
NCBI登录号
- NP_001135766
-
途径
- Regulation of Cell Size, SARS-CoV-2 Protein Interactome
抗原
-